Physician

Maury Nelson Blitman, MD

According to 2025 Medicare claims, Maury Blitman, MD (NPI: 1396713095) practices hematology/oncology in the Spokane-Spokane Valley, WA market, with the plurality of this provider's patient population coming from Spokane, WA. This provider's primary affiliated billing organization is CANCER CARE NORTHWEST CENTERS P S (NPI: 1922072081; TIN: 911007627) and primary practice location at 99216-1020. Blitman is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604) and Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Blitman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 498 traditional Medicare patients, billed 90,949 HCPCS/CPT codes, and received $1,618,594 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,124 prescription claims across 199 beneficiaries totaling $5,384,208 in drug costs, led by Jakafi (Ruxolitinib Phosphate). DME data shows 11 claims. Open Payments data shows 63 records totaling $23,550. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $635,517 and ending at $1,618,594. Concurrently, Part D prescription costs have risen steadily, from $448,834 to $5,384,208. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.